Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis

Bryan Yamamoto, Sheri Davy

Research output: Contribution to journalArticle

211 Citations (Scopus)

Abstract

Abstract: Glutamate and aspartate are the primary neurotransmitters of projections from motor and premotor cortices to the striatum. Release of glutamate may be modulated by dopamine receptors located on corticostriatal terminals. The present study used microdialysis to investigate the dopaminergic modulation of in vivo striatal glutamate and aspartate release in the striatum of awake‐behaving rats. Local perfusion with a depolarizing concentration of K+ through a dialysis probe into the rat striatum produced a significant increase in the release of glutamate, aspartate, and taurine. The D2 agonist LY171555 blocked the K+‐induced release of glutamate and aspartate, but not taurine, in a concentration‐dependent manner. The D1 agonist SKF 38393 did not alter K+‐induced release of glutamate and taurine, but did significantly decrease aspartate release. Neither agonist had any effect on basal amino acid release. The D2 antagonist (‐)‐sulpiride reversed the inhibitory effects of LY 171555 on K+‐induced glutamate release. These results provide in vivo evidence for a functional interaction between dopamine, the D2 receptor, and striatal glutamate release.

Original languageEnglish (US)
Pages (from-to)1736-1742
Number of pages7
JournalJournal of Neurochemistry
Volume58
Issue number5
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Microdialysis
Glutamic Acid
Modulation
Aspartic Acid
Taurine
4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrzolo(3,4-g)quinoline
Corpus Striatum
Motor Cortex
Rats
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Sulpiride
Dialysis
Dopamine D2 Receptors
Dopamine Receptors
Neurotransmitter Agents
Perfusion
Amino Acids

Keywords

  • Aspartate
  • Corticostriatal path
  • Dopamine
  • Glutamate
  • Microdialysis

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis. / Yamamoto, Bryan; Davy, Sheri.

In: Journal of Neurochemistry, Vol. 58, No. 5, 1992, p. 1736-1742.

Research output: Contribution to journalArticle

@article{9f159445a0dd4594ab6972033d90f663,
title = "Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis",
abstract = "Abstract: Glutamate and aspartate are the primary neurotransmitters of projections from motor and premotor cortices to the striatum. Release of glutamate may be modulated by dopamine receptors located on corticostriatal terminals. The present study used microdialysis to investigate the dopaminergic modulation of in vivo striatal glutamate and aspartate release in the striatum of awake‐behaving rats. Local perfusion with a depolarizing concentration of K+ through a dialysis probe into the rat striatum produced a significant increase in the release of glutamate, aspartate, and taurine. The D2 agonist LY171555 blocked the K+‐induced release of glutamate and aspartate, but not taurine, in a concentration‐dependent manner. The D1 agonist SKF 38393 did not alter K+‐induced release of glutamate and taurine, but did significantly decrease aspartate release. Neither agonist had any effect on basal amino acid release. The D2 antagonist (‐)‐sulpiride reversed the inhibitory effects of LY 171555 on K+‐induced glutamate release. These results provide in vivo evidence for a functional interaction between dopamine, the D2 receptor, and striatal glutamate release.",
keywords = "Aspartate, Corticostriatal path, Dopamine, Glutamate, Microdialysis",
author = "Bryan Yamamoto and Sheri Davy",
year = "1992",
doi = "10.1111/j.1471-4159.1992.tb10048.x",
language = "English (US)",
volume = "58",
pages = "1736--1742",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis

AU - Yamamoto, Bryan

AU - Davy, Sheri

PY - 1992

Y1 - 1992

N2 - Abstract: Glutamate and aspartate are the primary neurotransmitters of projections from motor and premotor cortices to the striatum. Release of glutamate may be modulated by dopamine receptors located on corticostriatal terminals. The present study used microdialysis to investigate the dopaminergic modulation of in vivo striatal glutamate and aspartate release in the striatum of awake‐behaving rats. Local perfusion with a depolarizing concentration of K+ through a dialysis probe into the rat striatum produced a significant increase in the release of glutamate, aspartate, and taurine. The D2 agonist LY171555 blocked the K+‐induced release of glutamate and aspartate, but not taurine, in a concentration‐dependent manner. The D1 agonist SKF 38393 did not alter K+‐induced release of glutamate and taurine, but did significantly decrease aspartate release. Neither agonist had any effect on basal amino acid release. The D2 antagonist (‐)‐sulpiride reversed the inhibitory effects of LY 171555 on K+‐induced glutamate release. These results provide in vivo evidence for a functional interaction between dopamine, the D2 receptor, and striatal glutamate release.

AB - Abstract: Glutamate and aspartate are the primary neurotransmitters of projections from motor and premotor cortices to the striatum. Release of glutamate may be modulated by dopamine receptors located on corticostriatal terminals. The present study used microdialysis to investigate the dopaminergic modulation of in vivo striatal glutamate and aspartate release in the striatum of awake‐behaving rats. Local perfusion with a depolarizing concentration of K+ through a dialysis probe into the rat striatum produced a significant increase in the release of glutamate, aspartate, and taurine. The D2 agonist LY171555 blocked the K+‐induced release of glutamate and aspartate, but not taurine, in a concentration‐dependent manner. The D1 agonist SKF 38393 did not alter K+‐induced release of glutamate and taurine, but did significantly decrease aspartate release. Neither agonist had any effect on basal amino acid release. The D2 antagonist (‐)‐sulpiride reversed the inhibitory effects of LY 171555 on K+‐induced glutamate release. These results provide in vivo evidence for a functional interaction between dopamine, the D2 receptor, and striatal glutamate release.

KW - Aspartate

KW - Corticostriatal path

KW - Dopamine

KW - Glutamate

KW - Microdialysis

UR - http://www.scopus.com/inward/record.url?scp=0026711063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026711063&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.1992.tb10048.x

DO - 10.1111/j.1471-4159.1992.tb10048.x

M3 - Article

VL - 58

SP - 1736

EP - 1742

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -